KANLUMA

Welcome to the Brand page for “KANLUMA”, which is offered here for Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of lysosmal acid lipase (lal) deficiency;.

Its status is currently believed to be active. Its class is unavailable. “KANLUMA” is believed to be currently owned by “SYNAGEVA BIOPHARMA CORP.”